Compound

Ambroxol

ATC Index

Ambroxol: Uses, Dosage, Side Effects & Mechanism of Action

Explore Ambroxol, a mucolytic agent (ATC R02) used to treat respiratory conditions by thinning mucus. Learn about its mechanism, dosage, side effects, and how to obtain it.

Ambroxol buy Ambroxol Ambroxol for sale Ambroxol dosage Ambroxol side effects mucolytic agent respiratory relief bronchitis treatment
ATC Code: R02
Last updated: Feb 23, 2026
Medical Reference

Looking to order Ambroxol?

Browse our catalog for available pharmaceutical products and competitive pricing.

View Products

What is Ambroxol?

Ambroxol is a well-established pharmaceutical compound primarily classified as a mucolytic and expectorant agent. Its main function in the body is to facilitate the clearance of mucus from the respiratory tract, making it easier to breathe. By thinning and breaking down thick, viscous sputum, Ambroxol helps to alleviate congestion and improve the overall efficiency of the mucociliary escalator – the body's natural defense mechanism for expelling foreign particles and pathogens from the lungs. This action makes it a cornerstone in the management of various acute and chronic respiratory conditions characterized by excessive or tenacious mucus production.

The history of Ambroxol traces back to its precursor, bromhexine, which was synthesized in the 1960s. Ambroxol itself was developed as an active metabolite of bromhexine, offering enhanced pharmacological properties and better tolerability. Since its introduction, it has gained widespread acceptance globally due to its efficacy and safety profile. Available in various formulations, including tablets, syrups, lozenges, and even injectable solutions, Ambroxol has become a staple in many medical settings for both adults and children, underscoring its versatility and importance in respiratory medicine.

Pharmacologically, Ambroxol belongs to the drug class of mucolytics and secretolytics. Its Anatomical Therapeutic Chemical (ATC) code is R02, which broadly categorizes drugs for the throat. More specifically, it falls under R02AX, designated for 'Other drugs for throat.' This classification reflects its primary application in conditions affecting the upper and lower respiratory tracts, where mucus accumulation contributes to symptoms like cough, difficulty breathing, and chest discomfort. As a secretolytic, it promotes the secretion of thinner, less viscous mucus, while its mucolytic action directly fragments the complex mucopolysaccharide chains that give sputum its thickness, thereby aiding in its expectoration.

⚙️ Mechanism of Action

The therapeutic efficacy of Ambroxol stems from its multifaceted mechanism of action within the respiratory system. At a cellular level, Ambroxol primarily works by stimulating the serous glands in the bronchial mucosa, leading to an increased production of serous mucus. This thinner, more watery fluid dilutes the viscous gel layer of mucus, making it less adhesive and easier to move. Concurrently, Ambroxol is known to activate depolymerizing enzymes, such as lysosomal enzymes, which break down the complex mucopolysaccharide chains within the mucus. This enzymatic degradation significantly reduces the viscosity and elasticity of sputum, further facilitating its clearance from the airways.

Beyond its direct effects on mucus consistency, Ambroxol also plays a crucial role in enhancing the body’s natural defense mechanisms. It promotes the synthesis and secretion of pulmonary surfactant by Type II pneumocytes. Surfactant is a lipoprotein complex that reduces surface tension in the alveoli, preventing their collapse, and also contributes to the fluidity of the periciliary layer, which is essential for effective ciliary beat. Furthermore, Ambroxol has been observed to stimulate ciliary activity, increasing the frequency and coordination of ciliary beats, which propels the thinned mucus upwards and out of the respiratory tract. Additionally, it exhibits mild local anesthetic properties, which can help alleviate throat irritation and cough reflex, particularly in oral lozenge formulations.

  • Increased serous mucus secretion from bronchial glands, leading to thinner sputum.
  • Enhanced production and secretion of pulmonary surfactant by Type II pneumocytes.
  • Depolymerization of mucopolysaccharide chains within mucus, reducing its viscosity.
  • Stimulation of ciliary activity, improving mucociliary clearance.
  • Exhibits mild local anesthetic effects, particularly in the throat.

🏥️ Medical Uses & Indications

Ambroxol is widely prescribed for a range of respiratory conditions where excessive or thick mucus production is a primary concern. Its ability to thin mucus and improve clearance makes it an invaluable tool in managing both acute and chronic bronchopulmonary diseases. The goal of Ambroxol therapy is to alleviate symptoms such as productive cough, chest congestion, and difficulty breathing, thereby enhancing patient comfort and respiratory function.

Primary Indications

  • Acute Bronchitis: To relieve productive cough and clear mucus associated with acute inflammation of the bronchial tubes.
  • Chronic Bronchitis and Emphysema: Used in exacerbations to help mobilize tenacious secretions, improving airway patency and reducing respiratory distress.
  • Bronchial Asthma with Mucus Hypersecretion: As an adjunct therapy to help clear mucus plugs that can worsen airway obstruction in asthmatic patients.
  • Bronchiectasis: To manage chronic production of large amounts of purulent, viscous sputum and reduce the frequency of infections.
  • Laryngitis and Pharyngitis: To help clear mucus and soothe throat irritation, particularly when accompanied by thick secretions.
  • Cystic Fibrosis: As an adjunctive therapy to help thin the abnormally thick mucus characteristic of this genetic disorder, improving lung function and reducing complications.

Secondary / Off-label Uses

  • Pre- and Post-operative Respiratory Care: Administered to prevent pulmonary complications like atelectasis (lung collapse) by ensuring clear airways, especially after thoracic or abdominal surgery.
  • Neonatal Respiratory Distress Syndrome (NRDS): While not a first-line treatment, some studies suggest its potential role in stimulating surfactant production in premature infants, though this is a specialized and monitored use.
  • Sinusitis and Otitis Media: In cases where thick mucus contributes to congestion and infection in the paranasal sinuses or middle ear, Ambroxol may aid in thinning secretions.
  • Local Anesthetic for Sore Throat: Low-dose lozenge formulations of Ambroxol are used for their local anesthetic effect to provide symptomatic relief from acute sore throat pain.

💊 Dosage & Administration

The dosage and administration of Ambroxol can vary significantly depending on the patient's age, weight, the specific medical condition being treated, and the formulation (e.g., tablets, syrup, sustained-release capsules, lozenges, or injectable solutions). It is crucial to always follow the precise instructions provided by a healthcare professional or the product's prescribing information to ensure optimal therapeutic effect and minimize potential side effects. Self-medication or altering prescribed dosages is not advised.

IndicationTypical DoseFrequencyRoute
Acute Bronchitis (Adults)30 mg2-3 times dailyOral (tablet/syrup)
Chronic Bronchitis (Adults)30-60 mgOnce daily (sustained-release) or 2-3 times dailyOral (tablet/syrup)
Sore Throat (Adults, lozenge)20 mgUp to 6 times dailyOral (lozenge)
Pediatric (2-5 years)15 mg2-3 times dailyOral (syrup)

Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition, and may be adjusted based on the severity of symptoms and individual response to Ambroxol therapy. For injectable forms, administration is typically intravenous and requires medical supervision.

⚠️ Side Effects

While Ambroxol is generally well-tolerated, like all medications, it can cause side effects. Most adverse reactions are mild and transient, resolving without intervention. However, patients should be aware of potential reactions and consult a healthcare professional if any side effects become bothersome or severe.

Common Side Effects (>10%)

  • Nausea
  • Vomiting
  • Diarrhea
  • Dyspepsia (indigestion)
  • Heartburn
  • Abdominal pain

Less Common (1-10%)

  • Skin rash (e.g., urticaria)
  • Pruritus (itching)
  • Dry mouth or throat
  • Dysgeusia (taste disturbance)
  • Numbness in the mouth or pharynx (especially with lozenge forms)

Rare but Serious

  • Anaphylactic reactions: These are severe, potentially life-threatening allergic reactions characterized by symptoms such as widespread rash, swelling of the face, lips, tongue, or throat, difficulty breathing, dizziness, and a rapid drop in blood pressure. Immediate medical attention is required.
  • Severe skin reactions: Very rarely, Ambroxol has been associated with severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). These conditions involve widespread blistering and peeling of the skin and mucous membranes and are medical emergencies. Discontinue Ambroxol immediately and seek urgent medical care if such symptoms develop.

🔄 Drug Interactions

Ambroxol is generally considered to have a favorable drug interaction profile, meaning it can often be safely co-administered with many other medications. However, certain interactions, though not always clinically significant, warrant caution or monitoring to ensure patient safety and therapeutic efficacy. Always inform your doctor or pharmacist about all medications, supplements, and herbal products you are currently taking before starting Ambroxol.

  • Antitussives (Cough Suppressants): Concurrent use of Ambroxol with cough suppressants like codeine or dextromethorphan is generally not recommended. By thinning mucus, Ambroxol promotes expectoration, and suppressing the cough reflex could lead to a dangerous accumulation of secretions in the airways, increasing the risk of respiratory obstruction and infection.
  • Antibiotics (e.g., Amoxicillin, Cefuroxime, Erythromycin): Ambroxol has been shown to enhance the penetration of certain antibiotics into bronchial secretions. This synergistic effect may improve the therapeutic outcome in respiratory infections, potentially leading to higher antibiotic concentrations at the site of infection.
  • Anticoagulants (e.g., Warfarin): While no clinically significant interaction has been consistently reported, patients on anticoagulants should be monitored for any unusual bleeding or bruising, as a theoretical risk cannot be entirely excluded. However, routine dose adjustments are typically not necessary.
  • Other Mucolytics: Combining Ambroxol with other mucolytic agents is generally not advised unless specifically instructed by a healthcare provider. While not strictly contraindicated, the benefit of combined therapy often does not outweigh the potential for increased side effects or mucus overload.
  • Bronchodilators: Ambroxol is frequently co-administered with bronchodilators in conditions like asthma or COPD. No significant adverse interactions have been identified, and their combined use can provide comprehensive relief from both bronchospasm and mucus obstruction.
  • Local Anesthetics: When used in lozenge form, Ambroxol’s mild local anesthetic properties can potentiate the effects of other topical anesthetics, leading to increased numbness in the mouth and throat.

🚫 Contraindications & Warnings

Before using Ambroxol, it is important to be aware of certain conditions where its use is contraindicated or requires significant caution. Always consult your healthcare provider to determine if Ambroxol is safe for you.

  • Hypersensitivity: Individuals with a known allergy or hypersensitivity to Ambroxol, bromhexine, or any of the excipients in the formulation should not use this medication. Allergic reactions can range from skin rashes to severe anaphylaxis.
  • Severe Liver or Kidney Impairment: Patients with severe hepatic or renal dysfunction should use Ambroxol with caution. Dosage adjustments may be necessary, as the drug is metabolized in the liver and excreted by the kidneys, potentially leading to accumulation.
  • Gastric or Duodenal Ulcers: Due to its potential for local irritation and its effect on gastric mucus, Ambroxol should be used with caution in patients with a history of gastric or duodenal ulcers, as it might exacerbate these conditions.
  • Pregnancy and Breastfeeding: Ambroxol is generally not recommended during the first trimester of pregnancy. For later trimesters and during breastfeeding, its use should only be considered if the potential benefits outweigh the potential risks to the fetus or infant, and under strict medical supervision.
  • Rare Hereditary Conditions: Certain formulations of Ambroxol may contain excipients like lactose or sorbitol. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, glucose-galactose malabsorption, or hereditary fructose intolerance should avoid these specific formulations.
  • Severe Skin Reactions History: Patients who have previously experienced severe skin reactions (like Stevens-Johnson syndrome or toxic epidermal necrolysis) with any medication should approach Ambroxol use with extreme caution and under medical guidance.
Medical Disclaimer: This information is for educational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication or treatment regimen. Never disregard professional medical advice or delay in seeking it because of something you have read here.

❓ Frequently Asked Questions

Is Ambroxol safe for long-term use?

Ambroxol is generally considered safe for long-term use, especially in chronic respiratory conditions like chronic bronchitis or bronchiectasis, when prescribed and monitored by a healthcare professional. Regular medical review is advised to assess its ongoing efficacy, monitor for any potential side effects, and ensure the dosage remains appropriate for the patient's evolving condition. While side effects are usually mild and infrequent, continuous use should always be under medical guidance to optimize benefits and minimize risks.

Can Ambroxol be taken with food?

Yes, Ambroxol can be taken with or without food. Its absorption and efficacy are not significantly affected by food intake. However, for individuals who experience mild gastrointestinal discomfort, such as nausea or heartburn, taking Ambroxol with a meal or a snack may help to reduce these symptoms. Always follow the specific instructions provided by your doctor or pharmacist regarding the timing of your dose.

What should I do if I miss a dose of Ambroxol?

If you miss a dose of Ambroxol, take it as soon as you remember, provided it is not almost time for your next scheduled dose. If it is nearly time for the next dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one, as this could increase the risk of side effects. Consistency in medication adherence is important for optimal therapeutic outcomes.

Where can I buy Ambroxol?

Ambroxol is available in various formulations and strengths globally. In many regions, particularly for higher doses or specific forms, Ambroxol requires a prescription from a licensed healthcare professional. It can then be purchased from reputable, licensed pharmacies. For over-the-counter (OTC) use, lower-dose formulations, such as lozenges for sore throat, might be available without a prescription in some countries. It is crucial to obtain Ambroxol only through legitimate medical channels to ensure product authenticity, quality, and safety, and to avoid potentially counterfeit or ineffective products from unregulated online sources.

Contact us on WhatsApp

Chat with our support team instantly on WhatsApp.

WhatsApp Chat on WhatsApp